Clinical Trial Eligibility Criteria Fulfill
Item
should fulfill the eligibility criteria for active a or active w trial and:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Systolic Pressure
Item
have a systolic blood pressure of at least 110 mmhg
boolean
C0871470 (UMLS CUI [1])
Angiotensin II receptor antagonist | Antihypertensive Agent Change Willing
Item
not already receiving an angiotensin receptor blocking agent, unless they are willing and able to be changed to another antihypertensive agent
boolean
C0521942 (UMLS CUI [1])
C0003364 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0600109 (UMLS CUI [2,3])
intolerance to Angiotensin II receptor antagonist
Item
no previous intolerance to angiotensin receptor blocking agents
boolean
C1744706 (UMLS CUI [1,1])
C0521942 (UMLS CUI [1,2])
Indication Angiotensin II receptor antagonist | Angiotensin-Converting Enzyme Inhibitors Substitution
Item
no proven indication for angiotensin receptor blocking agents, unless an angiotensin converting enzyme (ace) inhibitor can be substituted
boolean
C3146298 (UMLS CUI [1,1])
C0521942 (UMLS CUI [1,2])
C0003015 (UMLS CUI [2,1])
C1706204 (UMLS CUI [2,2])
ID.6
Item
patients will be excluded from active study if any of the following are present:
boolean
clopidogrel Requirement | Coronary stent placement
Item
requirement for clopidogrel (such as recent coronary stent procedure)
boolean
C0070166 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0948884 (UMLS CUI [2])
oral anticoagulants Requirement | Artificial cardiac valve prosthesis
Item
requirement for oral anticoagulant (such as prosthetic mechanical heart valve)
boolean
C0354604 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C3873910 (UMLS CUI [2])
intolerance to Aspirin | intolerance to clopidogrel
Item
prior intolerance to acetylsalicyclic acid (asa) or clopidogrel
boolean
C1744706 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
Peptic Ulcer
Item
documented peptic ulcer disease within the previous 6 months
boolean
C0030920 (UMLS CUI [1])
Cerebral Hemorrhage
Item
prior intracerebral hemorrhage
boolean
C2937358 (UMLS CUI [1])
Thrombocytopenia Significant | Platelet Count measurement
Item
significant thrombocytopenia (platelet count <50 x 10(9)/l)
boolean
C0040034 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0032181 (UMLS CUI [2])
Psychosocial Factors Causing Study Subject Participation Status Limited
Item
psychosocial reason making study participation impractical
boolean
C0033963 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,4])
Geographic Factors Causing Study Subject Participation Status Limited
Item
geographic reason making study participation impractical
boolean
C0017444 (UMLS CUI [1,1])
C0678227 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,4])
Alcohol abuse Continuous
Item
ongoing alcohol abuse
boolean
C0085762 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Mitral Stenosis
Item
mitral stenosis
boolean
C0026269 (UMLS CUI [1])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Not used | Contraceptive methods Unwilling
Item
pregnant or nursing woman or woman of child bearing potential and not on effective birth control for at least one month prior to start of study or not willing to continue on birth control for duration of study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0445107 (UMLS CUI [3,3])
C0700589 (UMLS CUI [4,1])
C0558080 (UMLS CUI [4,2])
Comorbidity Severe | Life Expectancy
Item
severe comorbid condition such that the patient is not expected to survive 6 months
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023671 (UMLS CUI [2])
Investigational New Drug
Item
patient currently receiving an investigational pharmacologic agent
boolean
C0013230 (UMLS CUI [1])
Cyclooxygenase 2 Inhibitors chronic Therapeutic procedure Requirement | Anti-Inflammatory Agents, Non-Steroidal chronic Therapeutic procedure Requirement
Item
requirement for chronic (> 3 months) non-cyclooxygenase-2 (non-cox-2) inhibitor nonsteroidal anti-inflammatory drug (nsaid) therapy unless willing enrolled in active a
boolean
C1257954 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,4])
C0003211 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0087111 (UMLS CUI [2,3])
C1514873 (UMLS CUI [2,4])